Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

14.270
-0.400-2.73%
Volume:9.75M
Turnover:140.05M
Market Cap:25.22B
PE:32.19
High:14.850
Open:14.000
Low:14.000
Close:14.670
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:1.25
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.443
ROE:12.77%
ROA:4.28%
PB:2.82
PE(LYR):32.19
PS:7.77

Loading ...

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum And Analyst Discount

Simply Wall St.
·
Apr 27

InnoCare Pharma Limited Just Missed Revenue By 19%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Apr 26

INNOCARE Calls 16 June AGM to Vote on 2026 Share Incentive Scheme, RSU Grants and Governance Amendments

Bulletin Express
·
Apr 24

Innocare Awards 15.39 Million Restricted Share Units

Stock News
·
Apr 24

InnoCare issues 15.39 million RSUs; executive portion subject to AGM vote

Bulletin Express
·
Apr 24

Stock Track | INNOCARE Soars 5.11% Intraday on Stellar Q1 2026 Results with 489% Net Profit Surge

Stock Track
·
Apr 24

Carbon Peak and Carbon Neutrality Evaluation Measures Released; Innocare Q1 Net Profit Surges 488.93%

Stock News
·
Apr 24

创新药企InnoCare 2025年度业绩显著提升,首度实现盈利并拓展多元业务布局

Bulletin Express
·
Apr 23

INNOCARE 2025 ESG Report: First-Time Profit, RMB 951.60 Million R&D Outlay and 60.75 % Carbon-Intensity Cut

Bulletin Express
·
Apr 23

InnoCare Pharma Q1 2026: Net Profit Jumps 4.9-Fold on 45% Drug-Sales Surge, Cash Pile Tops 7.92 Billion

Bulletin Express
·
Apr 23

Xie Zhiyu's Q1 Portfolio Revealed: Increased Bets on Chemical and Energy Storage Sectors

Stock News
·
Apr 21

InnoCare Pharma Sets 23 April Board Meeting to Approve Q1 2026 Unaudited Results

Bulletin Express
·
Apr 10

Assessing InnoCare Pharma (SEHK:9969) Valuation After Its 2025 Profit Turnaround

Simply Wall St.
·
Apr 08

Innocare Pharma Reports Annual Revenue of 23.75 Billion Yuan with 642 Million Yuan Net Profit; King Bridge Exits Entire Stake Potentially Realizing Over 2 Billion Yuan

Deep News
·
Apr 07

Goldman Sachs Slightly Raises Innocare Target to HK$19.93 on Strong Q4 Sales of Orelabrutinib

Stock News
·
Mar 30

A Look At InnoCare Pharma (SEHK:9969) Valuation After Recent Share Price Momentum

Simply Wall St.
·
Mar 30

The InnoCare Pharma Limited (HKG:9969) Yearly Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.
·
Mar 28

Stock Track | InnoCare Pharma Soars 5.08% Intraday on Strong Q4 Profit Surge

Stock Track
·
Mar 27

InnoCare Pharma (SEHK:9969) Q4 Profit Surge Challenges Bearish Earnings Narratives

Simply Wall St.
·
Mar 26

UBS Trims Innocare Pharma Target to HK$19.8, Keeps Buy Rating

Stock News
·
Mar 26